hGH fragment is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-09-14. Numbers and descriptions here follow the published literature rather than marketing material.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
| Property | Value | Notes |
|---|---|---|
| Common synonym | hGH fragment 176-191 | Refers to the C-terminal segment |
| Appearance | White to off-white powder | Typically supplied lyophilized |
| Solubility | Soluble in water and aqueous buffers | Confirm with technical data |
| Typical storage temperature | -20 °C for dry powder | Protect from moisture and light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
== Further reading == Reiter, Nadine; El-Shabrawi, Laila; Leinweber, Bernd; Berghold, Andrea; Aberer, Elisabeth (2011). "Calcinosis cutis". Journal of the American Academy of Dermatology. 65 (1): 15–22. doi:10.1016/j.jaad.2010.08.039. PMID 21679811. Róbert, Lili; Kiss, Norbert; Medvecz, Márta; Kuroli, Enikő; Sárdy, Miklós; Hidvégi, Bernadett (2020). "Epidemiology and treatment of calcinosis cutis: 13 years of experience". Indian Journal of Dermatology. 65 (2). Medknow: 105–111. doi:10.4103/ijd.ijd_527_18. ISSN 0019-5154. PMC 7059479. PMID 32180595.
== See also == List of abbreviations used in medical prescriptions List of medical roots, suffixes and prefixes Medical dictionary Medical slang Abbreviation#Style conventions in English Acronym and initialism#Orthographic styling
=== Founding === After their defeat at the convention, members of the two minority caucuses helped to found new socialist organizations. Harrington's Coalition Caucus created the Democratic Socialist Organizing Committee. The Debs Caucus, led by David McReynolds, formed the Union for Democratic Socialism. On May 30, 1973, the UDS incorporated the Socialist Party of the United States of America. Many activists from the local and state branches of the old Socialist Party of America, including the party's Wisconsin, California, Illinois, New York City, Philadelphia and Washington, D.C. organizations, participated in the reconstitution of SPUSA. After its founding, the party promoted itself as the legitimate heir of the Socialist Party of America. SPUSA elected Frank Zeidler, former Mayor of Milwaukee, as its first national chairperson. Later, SPUSA nominated Zeidler for President. Zeidler believed the party would be able to collaborate with other socialist parties nationwide to spread the message of socialism.
=== Indications === Persons with G6PD deficiency are asymptomatic. An attack of acute haemolytic anaemia can appear out of nowhere and can be very severe and life-threatening. Indications of such a sudden attack of favism are dark urine, pallor, jaundice, abdominal pain and in most cases fever.
=== Riboswitches bind cellular metabolites and control gene expression === Segments of RNA, typically embedded within the 5′-untranslated region of a vast number of bacterial mRNA molecules, have a profound effect on gene expression through a previously-undiscovered mechanism that does not involve the participation of proteins. In many cases, riboswitches change their folded structure in response to environmental conditions (e.g. ambient temperature or concentrations of specific metabolites), and the structural change controls the translation or stability of the mRNA in which the riboswitch is embedded. In this way, gene expression can be dramatically regulated at the post-transcriptional level.
Sources: en.wikipedia.org
The first island chain is the first string of major Pacific archipelagos out from the East Asian continental mainland coast. It is principally composed of the Kuril Islands, the Japanese archipelago, the Ryukyu Islands, Taiwan (Formosa), the northern Philippines, and Borneo, extending all the way from the Kamchatka Peninsula in the northeast to the Malay Peninsula in the southwest. The first island chain is one of three island chain doctrines within the island chain strategy of US foreign policy. It is considered a strategic military barrier to accessing the wider Pacific Ocean given the relative shallowness of waters to the west of the first island chain, which has important implications for submarine detection.
== Homicides == Thailand ranked 30 of 216 countries for its number of homicides (2,387) in 2015. Other ASEAN nations ranked: Philippines, 14 (9,756 homicides); Vietnam, 39 (1,358); Myanmar, 41 (1,304); Indonesia, 42 (1,277); Malaysia, 74 (540); Laos, 79 (467); Cambodia, 100 (268); Singapore, 175 (14); Brunei, 197 (2). Among ASEAN nations, the Philippines had the highest rate of homicides per 100,000 population (9.84), followed by Laos (6.87), and Thailand (3.51). Singapore had the lowest homicide rate in ASEAN, with just 0.25 murders per 100,000 population.
In the 1970s, Judi Sheppard Missett helped create the market for commercial aerobics with her Jazzercise program, at the same time as Jacki Sorensen was expanding her system of aerobic dancing. In the 1980s, Richard Simmons hosted an aerobic exercise show on television, and followed Jane Fonda's lead by releasing a series of exercise videos. In the 1990s, Billy Blanks's Tae Bo helped popularize cardio-boxing workouts that incorporated martial arts movements. Reebok shoes popularized step aerobics with their Reebok Step device and training program.
The Calvin cycle, also known as the dark reactions, is a series of biochemical reactions that fixes CO2 into G3P sugar molecules and uses the energy and electrons from the ATP and NADPH made in the light reactions. The Calvin cycle takes place in the stroma of the chloroplast. While named "the dark reactions", in most plants, they take place in the light, since the dark reactions are dependent on the products of the light reactions.
== Dissolution and successor organisations == In December 1998, Democratic Left in England and Wales was formally dissolved and reconstituted as the New Times Network, which adopted a more inclusive membership policy that welcomed members of the Labour Party and other political organisations. The new body published a monthly magazine, New Times, and worked with the Fabian Society to organise the 'Getting Real' conference in June 1999. The New Times Network was subsequently renamed the New Politics Network in December 1999. In Scotland, the organisation evolved separately into Democratic Left Scotland, which was established in May 1998.
Sources: en.wikipedia.org
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.
No. It is a shortened peptide fragment, not the full hormone. It does not contain the entire hGH sequence and is studied for different proposed effects.
Regulatory approvals for weight loss are not established in major jurisdictions. Some human trials reported modest changes, but the evidence is limited, and it remains a research compound.
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.